C12N 2710/16761
Methods of inactivation or attenuation
C12N2710/16761 (Methods of inactivation or attenuation) appears on 60 US grants and 66 published applications in this corpus.
Search patents in C12N- Granted patents
- 60
- Published applications
- 66
- Assignees
- 63
- Inventors
- 177
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 3 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 4 |
| 2004 | 2 | 4 |
| 2005 | 0 | 3 |
| 2006 | 0 | 3 |
| 2007 | 4 | 1 |
| 2008 | 1 | 5 |
| 2009 | 1 | 1 |
| 2010 | 3 | 2 |
| 2011 | 1 | 1 |
| 2012 | 0 | 3 |
| 2013 | 0 | 5 |
| 2014 | 5 | 1 |
| 2015 | 1 | 3 |
| 2016 | 0 | 11 |
| 2017 | 5 | 1 |
| 2018 | 1 | 2 |
| 2019 | 5 | 4 |
| 2020 | 3 | 1 |
| 2021 | 0 | 1 |
| 2022 | 3 | 2 |
| 2023 | 0 | 4 |
| 2024 | 1 | 1 |
| 2025 | 3 | 0 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method for production of Varicella Zoster Virus surface protein antigen29 Sep 2026US 12,747,427 B2The Green Cross Corporation
- Viral vaccines and methods of forming the same7 Oct 2025US 12,435,317 B2NDSU Research Foundation
- Recombinant virus with diminished latency and methods of using same13 May 2025US 12,296,004 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Environmentally compatible detergents for inactivation of lipid-enveloped viruses25 Mar 2025US 12,258,540 B2Takeda Pharmaceutical Company Limited
- Modulation of replicative fitness by deoptimization of synonymous codons17 Sep 2024US 12,090,197 B2The Government of the USA, as represented by the Secretary, Department of Health and Human Services
- Adjuvant for intradermal immunization and use thereof18 Jun 2026US 2026/0167942 A1Guotai (Taizhou) Center of Technology Innovation for Veterinary Biologicals, Taizhou
- Methods of vaccinating pigs against pseudorabies virus29 Jan 2026US 2026/0027199 A1Zoetis Services LLC
- Bovine herpesvirus type 1 (bohv-1) quadruple gene deleted mutant14 Mar 2024US 2024/0084325 A1The Boards of Supervisors of Louisiana State University and Agricultural and Mechanical College
- Replication-defective vaccines and uses thereof7 Dec 2023US 2023/0390386 A1Rutgers, The State University of New Jersey
- Modulation of replicative fitness by deoptimization of synonymous codons31 Aug 2023US 2023/0270833 A1The Government of the U.S.A. as represented by the Secretary of the Dept. of Health & Human Services
Most cited
By later US patents
- Preparation of inactivated viral vaccines49US 5,106,619 ADiamond Scientific Co. · 1992
- Recombinant herpesvirus of turkeys comprising a foreign DNA inserted into a non-essential region of the herpesvirus of turkeys genome34US 6,121,043 ASyntro Corporation · 2000
- Method of inactivating lipid-enveloped viruses32US 6,136,321 ABaxter Aktiengesellschaft · 2000
- Vaccines against Aujeszky's disease and other animal diseases containing pseudorabies virus mutants31US 5,674,500 AAkzo Nobel N. V. · 1997
- Vaccine against viruses associated with antibody-dependent-enhancement of viral infectivity27US 5,789,388 AAkzo Nobel N. V. · 1998